NCT01445002 - Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

October 31, 2012

Conditions

Grass Pollen Allergy

Interventions

BIOLOGICAL

BM32

Subcutaneous injection of 10 micrograms each of the BM32 components adsorbed on 0.3 mg of aluminum hydroxide every 4 week for a total of 3 injections

BIOLOGICAL

BM32

Subcutaneous injection of 20 micrograms of each of the BM32 components adsorbed on 0.6 mg of aluminum hydroxide every 4 weeks for a total of 3 injections

BIOLOGICAL

BM32

Subcutaneous injection of 40 micrograms of each of the BM32 components adsorbed on 1.2 mg of aluminum hydroxide every 4 weeks until a total of 3 injections

BIOLOGICAL

Placebo

Subcutaneous injection of 1.2 mg of aluminum hydroxide suspension every 4 weeks until 3 injections

Trial Locations (1)

1150

Allergy Center Vienna West, Vienna